What was MDB Capital Holdings, LLC Class A’s price range in the past 12 months?
MDB Capital Holdings, LLC Class A lowest stock price was $7.35 and its highest was $21.67 in the past 12 months.
What is MDB Capital Holdings, LLC Class A’s market cap?
Currently, no data Available
When is MDB Capital Holdings, LLC Class A’s upcoming earnings report date?
MDB Capital Holdings, LLC Class A’s upcoming earnings report date is Nov 13, 2024 which is in 165 days.
How were MDB Capital Holdings, LLC Class A’s earnings last quarter?
MDB Capital Holdings, LLC Class A released its earnings results on Apr 17, 2024. The company reported -$0.776 earnings per share for the quarter, missing the consensus estimate of N/A by -$0.776.
Does MDB Capital Holdings, LLC Class A pay dividends?
MDB Capital Holdings, LLC Class A does not currently pay dividends.
What is MDB Capital Holdings, LLC Class A’s EPS estimate?
MDB Capital Holdings, LLC Class A’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does MDB Capital Holdings, LLC Class A have?
MDB Capital Holdings, LLC Class A has 4,295,632 shares outstanding.
What happened to MDB Capital Holdings, LLC Class A’s price movement after its last earnings report?
MDB Capital Holdings, LLC Class A reported an EPS of -$0.776 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went up 4.024%.
Which hedge fund is a major shareholder of MDB Capital Holdings, LLC Class A?
Currently, no hedge funds are holding shares in MDBH
---
MDB Capital Holdings, LLC Class A Stock Smart Score
MDB Capital Holdings, LLC, through its subsidiaries, primarily operates as a broker-dealer. The company operates through two segments, Broker Dealer & Intellectual Property Service, and Technology Development. The Broker Dealer & Intellectual Property Service segment operates as a full-service broker dealer that focuses on conducting private and public securities offerings, as well as providing research services for investment banking due diligence. The Technology Development segment engages in the synthetic biology technology development business. The company was founded in 1997 and is based in Addison, Texas.